Mu has been working in pharmaceutical research and development at Gilead Sciences since March 2019. Prior to this role, Mu completed a Master's degree in Biological Science at the University of Washington, where studies took place from January 2001 to July 2004.
This person is not in the org chart
This person is not in any teams
This person is not in any offices